The Promising IgSF11 Immune Checkpoint Is Highly Expressed in Advanced Human Gliomas and Associates to Poor Prognosis

Glioma is the most prevalent primary brain tumor. Immune checkpoint blockade has made a great stride in mending patient’s clinical outcome for multiple types of cancers. However, PD-1, CTLA-4, or VEGF blockade exhibited only poor outcome in glioma patients. This study aimed to explore the expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghouzlani, Amina, Rafii, Soumaya, Karkouri, Mehdi, Lakhdar, Abdelhakim, Badou, Abdallah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884863/
https://www.ncbi.nlm.nih.gov/pubmed/33604291
http://dx.doi.org/10.3389/fonc.2020.608609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884863/
https://www.ncbi.nlm.nih.gov/pubmed/33604291
http://dx.doi.org/10.3389/fonc.2020.608609

Ejemplares similares